Bionirs is a pioneering brand that is dedicated to developing innovative technologies that harness the power of light to improve society's quality of life. Their primary focus is on creating a revolutionary medical imaging system for mammography in diffuse reflectance geometry using infrared light.

The brand's mission is to improve early breast cancer diagnosis, aiming to address the high incidence of late diagnosis and annual deaths caused by breast cancer. Bionirs' light-based diagnostic solutions offer several competitive advantages, including the provision of metabolic information, portability without requiring infrastructure, high specificity, and the ability to operate autonomously without the need for specialized operators.

With a dedicated team and strategic partners, Bionirs is at the forefront of enlightening biomedicine. Led by experienced professionals such as CEO Pamela Pardini and CTO Nicolás Carbone, the team is committed to driving technological advancements in the field of biomedicine.

Founded in 2005, Bionirs has achieved significant milestones, including winning awards, securing investments, and developing prototypes. They are poised to embark on their first clinical trials in 2022. Join Bionirs in their mission by becoming a partner and stay updated by following them on social media.